| Literature DB >> 35763120 |
Vincent P Klink1,2,3, Nadim W Alkharouf4, Kathy S Lawrence5,6, Bisho R Lawaju5,7,8, Keshav Sharma9,7,10, Prakash M Niraula9,7,11, Brant T McNeece9,7,12.
Abstract
Two conserved Glycine max (soybean) mitogen activated protein kinase 3 (MAPK3) paralogs function in defense to the parasitic soybean cyst nematode Heterodera glycines. Gene Ontology analyses of RNA seq data obtained from MAPK3-1-overexpressing (OE) and MAPK3-2-OE roots compared to their control, as well as MAPK3-1-RNA interference (RNAi) and MAPK3-2-RNAi compared to their control, hierarchically orders the induced and suppressed genes, strengthening the hypothesis that their heterologous expression in Gossypium hirsutum (upland cotton) would impair parasitism by the root knot nematode (RKN) Meloidogyne incognita. MAPK3-1 expression (E) in G. hirsutum suppresses the production of M. incognita root galls, egg masses, and second stage juveniles (J2s) by 80.32%, 82.37%, and 88.21%, respectfully. Unexpectedly, egg number increases by 28.99% but J2s are inviable. MAPK3-2-E effects are identical, statistically. MAPK3-1-E and MAPK3-2-E decreases root mass 1.49-fold and 1.55-fold, respectively, as compared to the pRAP15-ccdB-E control. The reproductive factor (RF) of M. incognita for G. hirsutum roots expressing MAPK3-1-E or MAPK3-2-E decreases 60.39% and 50.46%, respectively, compared to controls. The results are consistent with upstream pathogen activated molecular pattern (PAMP) triggered immunity (PTI) and effector triggered immunity (ETI) functioning in defense to H. glycines. The experiments showcase the feasibility of employing MAPK3, through heterologous expression, to combat M. incognita parasitism, possibly overcoming impediments otherwise making G. hirsutum's defense platform deficient. MAPK homologs are identified in other important crop species for future functional analyses.Entities:
Keywords: Cotton; Effector triggered immunity (ETI) pathogen associated molecular pattern (PAMP) triggered immunity (PTI); Gene Ontology; Glycine max; Gossypium hirsutum; Mitogen activated protein kinase (MAPK); Overexpression; Plant parasitic nematode; RNA interference (RNAi); Soybean
Mesh:
Substances:
Year: 2022 PMID: 35763120 PMCID: PMC9489592 DOI: 10.1007/s11248-022-00312-y
Source DB: PubMed Journal: Transgenic Res ISSN: 0962-8819 Impact factor: 3.145
Fig. 1Gene Ontology analysis of the MAPK3-1-OE and MAPK3-1-RNAi induced and suppressed genes. A MAPK3-1-OE induced genes GO analysis B MAPK3-1-OE suppressed genes C MAPK3-1-RNAi induced genes GO analysis D MAPK3-1-RNAi suppressed genes GO analysis. Gene Ontologies, specifically molecular function, are retrieved from Phytozome, using the PhytoMine tool (https://phytozome.jgi.doe.gov/phytomine/begin.do) (Goodstein et al. 2012). Graphs are generated using Excel
Presented are gene counts for the MAPK3-1-OE and MAPK3-1-RNAi roots compared to their pRAP15-ccdB (overexpression) and pRAP17-ccdB (RNAi) control, as well as the MAPK3-2-OE and MAPK3-2-RNAi roots as compared to their pRAP15-ccdB and pRAP17-ccdB control, and genes in common between the two
| Gene count | MAPK3-1-OE | MAPK3-2-OE | Common-OE | Common-OE-highly |
|---|---|---|---|---|
| Induced | 4669 | 5129 | 1930 | 76 |
| Suppressed | 5611 | 5487 | 3314 | 115 |
Presented are the top 10 most highly induced or most highly suppressed genes for MAPK3-1-OE, MAPK3-1-RNAi, MAPK3-2-OE, MAPK3-2-RNAi analyses as compared to their respective pRAP15-ccdB-OE or pRAP17-ccdB-RNAi controls
| Analysis type | Gene name | M | Probability | Gene description |
|---|---|---|---|---|
| MAPK3-1-O-I | Glyma.01G118000 | 11.13887385 | 0.999965546 | Thiamine pyrophosphate dependent pyruvate decarboxylase |
| Glyma.03G221350 | 11.07438979 | 0.999800404 | glycerol-3-phosphate acyltransferase 2 | |
| Glyma.03G221350 | 11.07438979 | 0.999800404 | AMP-dependent synthetase and ligase protein | |
| Glyma.03G220751 | 11.00644046 | 0.999784959 | ||
| Glyma.14G176800 | 10.53199868 | 0.999610312 | Protein of unknown function (DUF1637) | |
| Glyma.04G213900 | 9.925603452 | 1 | alcohol dehydrogenase 1 | |
| Glyma.16G037600 | 9.86286902 | 1 | Protein of unknown function (DUF1637) | |
| Glyma.05G123700 | 9.679251852 | 0.9989343 | polygalacturonase inhibiting protein 1 | |
| Glyma.05G230300 | 9.625563981 | 0.998836878 | ||
| Glyma.08G012900 | 9.569800709 | 0.998764405 | nucleotide binding | |
| MAPK3-1-O-S | Glyma.15G062800 | − 11.85480717 | 1 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) |
| Glyma.19G151200 | − 11.47798233 | 0.999891885 | Disease resistance-responsive (dirigent-like protein) protein | |
| Glyma.04G113400 | − 10.98440838 | 0.999781395 | FAD-binding Berberine protein | |
| Glyma.13G252400 | − 10.97208198 | 0.999989307 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) | |
| Glyma.19G151100 | − 10.92629967 | 0.999976239 | Disease resistance-responsive (dirigent-like protein) family protein | |
| Glyma.13G251700 | − 10.84098913 | 0.99972912 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) | |
| Glyma.U039500 | − 10.74842301 | 0.999694666 | Pseudouridine synthase protein | |
| Glyma.02G156100 | − 10.61357703 | 0.999897826 | Cytochrome p450, family 71, subfamily B, polypeptide 11 | |
| Glyma.17G014400 | − 9.893019833 | 0.999152905 | ||
| Glyma.17G014100 | − 9.850461739 | 0.999921587 | ||
| MAPK3-1-R-I | Glyma.19G069300 | 7.745442218 | 0.989701409 | Protein kinase |
| Glyma.10G098400 | 7.202649172 | 0.98195114 | Protein kinase | |
| Glyma.03G054100 | 6.289063923 | 0.953146207 | Disease resistance protein (TIR-NBS-LRR class) | |
| Glyma.18G254300 | 6.255116591 | 0.951419245 | Leucine-rich repeat receptor-like protein kinase family protein | |
| Glyma.07G178200 | 6.148201388 | 0.945461459 | Cupredoxin protein | |
| Glyma.14G015300 | 6.110726682 | 0.945461459 | multidrug resistance-associated protein 3 | |
| Glyma.18G250500 | 6.072252534 | 0.943150653 | Leucine-rich repeat receptor-like protein kinase | |
| Glyma.02G028400 | 5.95026201 | 0.93525764 | ||
| Glyma.12G054700 | 5.816995479 | 0.9254294 | lipoxygenase 2 | |
| Glyma.05G204800 | 5.782405297 | 0.979021388 | osmotin 34 | |
| MAPK3-1-R-S | Glyma.14G200900 | − 8.24082926 | 0.997733655 | O-methyltransferase |
| Glyma.17G011100 | − 6.874809738 | 0.97459751 | Stigma-specific Stig1 protein | |
| Glyma.15G145600 | − 5.918901165 | 0.97171573 | MLP-like protein 423 | |
| Glyma.06G195000 | − 4.929548409 | 0.984304067 | expansin A15 | |
| Glyma.13G112400 | − 4.863343188 | 0.999120139 | Integrase-type DNA-binding protein | |
| Glyma.03G173200 | − 4.674975582 | 0.902971873 | C2H2 and C2HC zinc fingers protein | |
| Glyma.19G175200 | − 4.636501434 | 0.992576169 | exocyst subunit exo70 family protein H4 | |
| Glyma.10G262600 | − 4.621426114 | 0.997790986 | plant U-box 22 | |
| Glyma.15G180000 | − 4.471442188 | 0.998958675 | Integrase-type DNA-binding superfamily protein | |
| Glyma.19G132500 | − 4.427048068 | 0.951391164 | basic helix-loop-helix (bHLH) DNA-binding protein | |
| MAPK3-2-O-I | Glyma.18G033200 | 9.804556228 | 0.999903986 | Bifunctional inhibitor/lipid-transfer protein/seed storage 2S albumin protein |
| Glyma.16G148300 | 9.365338569 | 0.999130017 | spermidine hydroxycinnamoyl transferase | |
| Glyma.03G058950 | 9.03276323 | 0.99873308 | glycosyl hydrolase 9B7 | |
| Glyma.09G129100 | 8.804556228 | 0.999674488 | WRKY family transcription factor | |
| Glyma.10G177400 | 8.793575566 | 0.998289307 | Protein of unknown function (DUF1442) | |
| Glyma.13G222100 | 8.408839339 | 1 | senescence-related gene 1 | |
| Glyma.19G199900 | 8.375364635 | 0.999432111 | Aluminium activated malate transporter protein | |
| Glyma.05G036300 | 8.365338569 | 0.997186314 | spermidine synthase 1 | |
| Glyma.07G034900 | 8.277875728 | 0.99687017 | lipoxygenase 1 | |
| Glyma.07G092700 | 8.266560414 | 0.99683153 | BR enhanced expression 1 | |
| MAPK3-2-O-S | Glyma.13G252400 | − 12.18443627 | 0.999995316 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) |
| Glyma.02G156100 | − 11.51884455 | 0.9999356 | cytochrome p450, family 71, subfamily B, polypeptide 11 | |
| Glyma.15G156100 | − 11.46107059 | 1 | cytochrome P450, family 81, subfamily D, polypeptide 3 | |
| Glyma.15G062800 | − 11.06282253 | 1 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) | |
| Glyma.U033205 | − 10.92877516 | 0.999868859 | disease resistance protein (TIR-NBS-LRR class), putative | |
| Glyma.13G251700 | − 10.84179186 | 0.99985832 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) | |
| Glyma.18G239100 | − 10.80672821 | 0.999850124 | S-adenosyl-L-methionine-dependent methyltransferase | |
| Glyma.13G162700 | − 10.79414648 | 0.999847782 | RING/U-box superfamily protein | |
| Glyma.10G184600 | − 10.58381569 | 0.999995316 | Serine protease inhibitor, potato inhibitor I-type protein | |
| Glyma.16G170000 | − 10.31603372 | 1 | ||
| MAPK3-2-R-I | Glyma.02G240600 | 13.85812251 | 1 | glutathione S-transferase TAU 19 |
| Glyma.09G201500 | 13.68881465 | 1 | Concanavalin A-like lectin protein kinase | |
| Glyma.11G095900 | 13.62842779 | 1 | Bifunctional inhibitor/lipid-transfer protein/seed storage 2S albumin protein | |
| Glyma.08G274700 | 13.55386329 | 1 | Concanavalin A-like lectin protein kinase | |
| Glyma.09G201600 | 13.35615704 | 1 | Concanavalin A-like lectin protein kinase | |
| Glyma.14G123500 | 13.30236808 | 1 | phosphate transporter 1;1 | |
| Glyma.09G201400 | 13.27673576 | 1 | Concanavalin A-like lectin protein kinase | |
| Glyma.14G210100 | 13.26262798 | 1 | glutathione S-transferase TAU 19 | |
| Glyma.13G291100 | 13.07694796 | 0.999998826 | Protein of unknown function, DUF538 | |
| Glyma.12G210200 | 12.89925823 | 0.999997653 | Protein of unknown function, DUF538 | |
| MAPK3-2-R-S | Glyma.03G176300 | − 9.17880158 | 0.997912021 | Glutathione S-transferase |
| Glyma.04G113400 | − 9.031525318 | 0.997551701 | FAD-binding Berberine protein | |
| Glyma.20G036100 | − 8.873687809 | 0.999893195 | ribonuclease 1 | |
| Glyma.19G176600 | − 8.665097763 | 0.996298209 | Protein phosphatase 2C | |
| Glyma.01G021000 | − 8.57546055 | 0.995956668 | elicitor-activated gene 3–2 | |
| Glyma.10G016600 | − 8.366873928 | 0.99490857 | Pollen Ole e 1 allergen and extensin | |
| Glyma.15G062800 | − 7.970952843 | 0.999913148 | CAP (Cysteine-rich secretory proteins, Antigen 5, Pathogenesis-related 1) | |
| Glyma.15G103000 | − 7.85991394 | 0.991189174 | Family of unknown function (DUF716) | |
| Glyma.03G215900 | − 7.833172649 | 0.997895589 | Plant invertase/pectin methylesterase inhibitor superfamily | |
| Glyma.19G144800 | − 7.813620287 | 0.990732612 | geranylgeranyl pyrophosphate synthase 1 |
Analyzed samples: MAPK3-1-O-I, MAPK3-1 overexpression, induced genes; MAPK3-1-O-S, MAPK3-1 overexpression, suppressed genes; MAPK3-1-R-I, MAPK3-1-RNAi, induced genes; MAPK3-1-R-S, MAPK3-1-RNAi, suppressed genes; MAPK3-2-O-I, MAPK3-2 overexpression, induced genes; MAPK3-2-O-S, MAPK3-2 overexpression, suppressed genes; MAPK3-2-R-I, MAPK3-2-RNAi, induced genes; MAPK3-2-RNAi-S, MAPK3-2-RNAi, suppressed genes. M, relative fold change in transcript abundance
G. hirsutum MAPK3 genes as identified by comparison to the G. max MAPK3-1 and G. max MAPK3-2 protein sequences
| Percent identity | Percent identity | ||
|---|---|---|---|
| Gohir.D03G132800.1.p | 85 | Gohir.D03G132800.1.p | 85 |
| Gohir.A03G035400.1.p | 85 | Gohir.A03G035400.1.p | 85 |
| Gohir.D05G100500.1.p | 85 | Gohir.D05G100500.1.p | 85 |
| Gohir.A03G088300.1.p | 82 | Gohir.A03G088300.1.p | 83 |
| Gohir.D02G108500.1.p | 79 | Gohir.D02G108500.1.p | 79 |
| Gohir.A02G009100.1.p | 79 | Gohir.A02G009100.1.p | 79 |
Presented are the top 10 most highly induced or suppressed genes for MAPK3-1-OE and MAPK3-2-OE expressed in common in comparison to the pRAP15-ccdB control and also genes in common between MAPK3-1-RNAi and MAPK3-2-RNAi analyses as compared to the pRAP17-ccdB control
| Analysis type | Gene name | M (MAPK3− 1) | Probability | M (MAPK3− 2) | Probability | Gene description |
|---|---|---|---|---|---|---|
| MAPK3-1-MAPK3-2-O-I | Glyma.03G221350 | 11.07438979 | 0.999800404 | 7.277875728 | 0.989800244 | glycerol-3-phosphate acyltransferase 2 |
| Glyma.05G123700 | 9.679251852 | 0.9989343 | 5.67019315 | 0.928527938 | polygalacturonase inhibiting protein 1 | |
| Glyma.05G123900 | 9.384390768 | 0.999697042 | 5.711044343 | 0.986609526 | polygalacturonase inhibiting protein 1 | |
| Glyma.20G098300 | 8.981408771 | 1 | 5.093513979 | 0.99970259 | Inorganic H pyrophosphatase family protein | |
| Glyma.15G052600 | 8.727888223 | 0.99999406 | 6.176707915 | 0.999894619 | Peroxidase superfamily protein | |
| Glyma.03G079150 | 8.711819714 | 0.996805275 | 7.300243541 | 0.990001639 | n/a | |
| Glyma.08G179800 | 7.82332803 | 0.991714388 | 5.525803241 | 0.918819962 | Peroxidase superfamily protein | |
| Glyma.18G263200 | 7.799282556 | 0.991449448 | 7.365338569 | 0.99059763 | multidrug resistance-associated protein 3 | |
| Glyma.16G038000 | 7.396317889 | 0.986933587 | 6.599803823 | 0.97683598 | dehydrin family protein | |
| Glyma.16G037800 | 7.395267357 | 0.996973981 | 6.645156407 | 0.99571917 | Plant protein of unknown function (DUF639) | |
| MAPK3-1-MAPK3-2-O-S | Glyma.15G062800 | − 11.8548072 | 1 | − 11.06282253 | 1 | CAP (Cysteine-rich secretory protein, Antigen 5, Pathogenesis-related 1) |
| Glyma.19G151200 | − 11.4779823 | 0.999891885 | − 6.615946832 | 0.999891885 | Disease resistance-responsive (dirigent-like protein) family protein | |
| Glyma.04G113400 | − 10.9844084 | 0.999781395 | − 5.247903758 | 0.999781395 | FAD-binding Berberine family protein | |
| Glyma.13G252400 | − 10.972082 | 0.999989307 | − 12.18443627 | 0.999989307 | CAP (Cysteine-rich secretory protein, Antigen 5, Pathogenesis-related 1) | |
| Glyma.19G151100 | − 10.9262997 | 0.999976239 | − 8.231763364 | 0.999976239 | Disease resistance-responsive (dirigent-like protein) family protein | |
| Glyma.13G251700 | − 10.8409891 | 0.99972912 | − 10.84179186 | 0.99972912 | CAP (Cysteine-rich secretory protein, Antigen 5, Pathogenesis-related 1) | |
| Glyma.02G156100 | − 10.613577 | 0.999897826 | − 11.51884455 | 0.999897826 | cytochrome p450, family 71, subfamily B, polypeptide 11 | |
| Glyma.10G176700 | − 9.31126913 | 0.999983367 | − 10.16105334 | 0.999983367 | O-methyltransferase family protein | |
| Glyma.03G032400 | − 9.16519087 | 0.999961982 | − 8.529548258 | 0.999961982 | SPX domain gene 3 | |
| Glyma.07G262400 | − 8.99248074 | 0.999155281 | − 6.297944441 | 0.999155281 | F-box family protein with a domain of unknown function (DUF295) | |
| MAPK3-1-MAPK3-2-R-I | Glyma.10G098400 | 7.202649172 | 0.98195114 | 7.900217783 | 0.991523673 | Protein kinase superfamily protein |
| Glyma.18G254300 | 6.255116591 | 0.951419245 | 5.930591432 | 0.938551912 | Leucine-rich repeat receptor-like protein kinase | |
| Glyma.14G015300 | 6.110726682 | 0.945461459 | 8.505500268 | 0.995629211 | multidrug resistance-associated protein 3 | |
| Glyma.12G054700 | 5.816995479 | 0.9254294 | 7.073549386 | 0.980062675 | lipoxygenase 2 | |
| Glyma.05G204800 | 5.782405297 | 0.979021388 | 6.498514096 | 0.990454449 | osmotin 34 | |
| Glyma.13G065451 | 5.720780164 | 0.917502457 | 6.515553933 | 0.965221474 | n/a | |
| Glyma.20G229700 | 5.681476388 | 0.976352553 | 7.810458102 | 0.997720711 | n/a | |
| Glyma.18G067200 | 5.506655358 | 0.902978893 | 5.433091772 | 0.902032816 | alpha-glucan phosphorylase 2 | |
| Glyma.16G151500 | 5.479842527 | 0.970934151 | 7.980383103 | 0.998109199 | NAC domain containing protein 47 | |
| Glyma.13G267600 | 5.475025511 | 0.997618992 | 7.490198828 | 0.999863853 | WRKY DNA-binding protein 62 | |
| MAPK3-1-MAPK3-2-R-S | Glyma.15G145600 | − 5.91890116 | 0.97171573 | − 6.781911428 | 0.973329265 | MLP-like protein 423 |
Analyzed samples: MAPK3-1-MAPK3-2-O-I, MAPK3-1 and MAPK3-2 overexpression, induced genes; MAPK3-1-MAPK3-2-O-S, MAPK3-1 and MAPK3-2 overexpression, suppressed genes; MAPK3-1-MAPK3-2-R-I, MAPK3-1 and MAPK3-2 RNAi, induced genes; MAPK3-1-MAPK3-2-RNAi-S, MAPK3-1 and MAPK3-2 RNAi, suppressed genes
Fig. 2Gene Ontology analysis of the MAPK3-2-OE and MAPK3-2-RNAi induced and suppressed genes. A MAPK3-2-OE induced genes GO analysis B MAPK3-2-OE suppressed genes C MAPK3-2-RNAi induced genes GO analysis D MAPK3-2-RNAi suppressed genes GO analysis. Gene Ontologies, specifically molecular function, are retrieved from Phytozome, using the PhytoMine tool (https://phytozome.jgi.doe.gov/phytomine/begin.do) (Goodstein et al. 2012). Graphs are generated using Excel
Fig. 3Gene Ontology analysis of the MAPK3-1-OE and MAPK3-2-OE genes expressed in common, and MAPK3-1-RNAi and MAPK3-2-RNAi genes expressed in common, induced and suppressed genes. A MAPK3-1-OE and MAPK3-2-OE induced genes GO analysis-B MAPK3-1-OE and MAPK3-2-OE suppressed genes C MAPK3-1-RNAi and MAPK3-2-RNAi induced genes GO analysis D MAPK3-1-RNAi and MAPK3-2-RNAi suppressed genes GO analysis. Gene Ontologies, specifically molecular function, are retrieved from Phytozome, using the PhytoMine tool (https://phytozome.jgi.doe.gov/phytomine/begin.do) (Goodstein et al. 2012). Graphs are generated using Excel
Fig. 4Generation of transgenic roots. A a representative pRAP15-ccdB control root revealed by the eGFP reporter. Bar = 1 cm. B a representative G. max MAPK3-1-expressing engineered root revealed by the eGFP reporter. Bar = 1 cm. C a representative G. max MAPK3-2-expressing engineered root revealed by the eGFP reporter. Bar = 1 cm. D representative PCR has been used to demonstrate the presence of the MAPK3-1 and MAPK3-2 transcript only in the transgenic MAPK3-1 and MAPK3-2 expressing lines in comparison to the control. 1 DNA ladder with base pairs indicated; 2 no template control; 3 MAPK3-1-expressing transgenic G. hirsutum root; 4 MAPK3-2-expressing transgenic G. hirsutum; 5 eGFP from CDNA made from an eGPF fluorescing MAPK3-1-expressing transgenic G. hirsutum root; 6 MAPK3-2-expressing transgenic G. hirsutum root; 7 transgenic G. hirsutum root engineered only with the pRAP15-ccdB eGFP expressing root. The MAPK3-1 transcript is 1486 base pairs (bp). The MAPK3-2 transcript cDNA is 1488 bp. The eGFP transcript cDNA is 864 bp
Fig. 5M. incognita gall analyses in whole roots (wr) and per gram (pg) of root tissue show G. hirsutum roots genetically engineered to express MAPK (MK) MK3-1 and MK3-2 affects their parasitism. A Total change in galls as compared to the control. B Transformed data From A showing percent change in galls as compared to the control. *, **, and *** denote statistical significance at the 0.05, 0.01, 0.001 probability level, respectively. Significance determined using Mann–Whitney-Wilcoxon Rank Sum Test (Mann and Whitney 1947). The number of experimental replicates, spanning the 3 biological replicates, include 30 MAPK3-1-E roots, 40 MAPK3-1-E roots, and 30 total pRAP15-ccdB-E roots. Please refer to Materials and Methods section, subsection: G. hirsutum genetic transformation, for details
Fig. 6M. incognita egg mass analyses in whole roots (wr) and per gram (pg) of root tissue show G. hirsutum roots genetically engineered to express MAPK (MK) MK3-1 and MK3-2 affects their parasitism. A Total change in egg masses as compared to the control. B Transformed data From A showing percent change in egg masses as compared to the control. *, **, and *** denote statistical significance at the 0.05, 0.01, 0.001 probability level, respectively. Significance determined using Mann–Whitney-Wilcoxon Rank Sum Test (Mann and Whitney 1947). The number of experimental replicates, spanning the 3 biological replicates, include 30 MAPK3-1-E roots, 40 MAPK3-1-E roots, and 30 total pRAP15-ccdB-E roots. Please refer to Materials and Methods section, subsection: G. hirsutum genetic transformation, for details
Fig. 7M. incognita egg analyses in whole roots (wr) and per gram (pg) of root tissue show G. hirsutum roots genetically engineered to express MAPK (MK) MK3-1 and MK3-2 affects their parasitism. A. Total change in eggs as compared to the control. B. Transformed data From A showing percent change in eggs as compared to the control. *, **, and *** denote statistical significance at the 0.05, 0.01, 0.001 probability level, respectively. Significance determined using Mann–Whitney-Wilcoxon Rank Sum Test (Mann and Whitney 1947). The number of experimental replicates, spanning the 3 biological replicates, include 30 MAPK3-1-E roots, 40 MAPK3-1-E roots, and 30 total pRAP15-ccdB-E roots. Please refer to Materials and Methods section, subsection: G. hirsutum genetic transformation, for details
Fig. 8M. incognita J2 analyses in whole roots (wr) and per gram (pg) of root tissue show G. hirsutum roots genetically engineered to express MAPK (MK) MK3-1 and MK3-2 affects their parasitism. A. Total change in J2s as compared to the control. B. Transformed data From A showing percent change in J2s as compared to the control. *, **, and *** denote statistical significance at the 0.05, 0.01, 0.001 probability level, respectively. Significance determined using Mann–Whitney-Wilcoxon Rank Sum Test (Mann and Whitney 1947). The number of experimental replicates, spanning the 3 biological replicates, include 30 MAPK3-1-E roots, 40 MAPK3-1-E roots, and 30 total pRAP15-ccdB-E roots. Please refer to Materials and Methods section, subsection: G. hirsutum genetic transformation, for details
Fig. 9Root growth in relation to MAPK3 (MK3) expression. Root growth is calculated as a percent with MK3-1 and MK3-2 average fresh weight divided by the pRAP15-ccdB control average fresh weight multiplied by 100. In each analysis the results are considered statistically significant if p < 0.05, determined using Mann–Whitney-Wilcoxon Rank Sum Test (Mann and Whitney 1947). A. Total change in root mass. B. Transformed data From A showing percent change in J2s as compared to the control. *, **, and *** denote statistical significance at the 0.05, 0.01, 0.001 probability level, respectively. The number of experimental replicates, spanning the 3 biological replicates, include 30 MAPK3-1-E roots, 40 MAPK3-1-E roots, and 30 total pRAP15-ccdB-E roots. please refer to Materials and Methods section, subsection: G. hirsutum genetic transformation, for details
Fig. 10Comparison of the percent effect that G. max MAPK3-1 or MAPK3-2 expression has on M. incognita gall, egg mass, eggs and J2 production to prior analyses of NPR1-2, NDR1-1, g-4, and XTH43. *, ** NPR1-2, g-4 (Pant et al. 2016), *** NDR1-1 (McNeece et al. 2017), **** XTH43 (Niraula et al. 2020a)
Fig. 11Model. G. max ETI and PTI genes expressed in G. hirsutum lead to a defense response. These functioning genes include the ETI gene NDR1 which acts with RIN4, RPM1, and RPS2, whose expression leads to MAPK expression and downstream gene expression including the expression of the secreted genes g-4, and XTH43. PTI genes including PRRs, the co-receptor BAK1, the associated cytoplasmic kinase BIK1 lead to induced EDS1 and NPR1 expression. PTI and ETI cross communicate. EDS1 signals through NPR1 to activate the transcription of downstream genes functioning in defense. G. max genes denoted with hashed lines (i.e., EDS1, BIK1, RIN4, RPM1, RPS2) have not been heterologously expressed in G. hirsutum. Genes with solid lines (i.e., MAPK3-1, MAPK3-2, NPR1-2, g-4, XTH43) have been heterologously expressed in G. hirsutum (Yi et al. 2015; Pant et al. 2016; McNeece et al. 2017; Chen et al. 2017; Liu et al. 2020; Yuan et al. 2021; Niraula et al. 2020a, b)